Cargando…
Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids
Here we sought to determine the relationship between STAT3 activity and Galectin‐3 (Gal‐3) and to investigate the cytotoxic effect of PectaSol‐C Modified Citrus Pectin (Pect‐MCP) as a specific competitive inhibitor of Galectin‐3 (Gal‐3) in combination with Paclitaxel (PTX) to kill the ovarian cancer...
Autores principales: | Hossein, Ghamartaj, Halvaei, Sina, Heidarian, Yassaman, Dehghani‐Ghobadi, Zeinab, Hassani, Mina, Hosseini, Homa, Naderi, Nima, Sheikh Hassani, Shahrzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675724/ https://www.ncbi.nlm.nih.gov/pubmed/31197964 http://dx.doi.org/10.1002/cam4.2334 |
Ejemplares similares
-
Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
por: Lau, Emily S., et al.
Publicado: (2021) -
Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation
por: Dehghani-Ghobadi, Zeinab, et al.
Publicado: (2022) -
Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
por: Kolatsi-Joannou, Maria, et al.
Publicado: (2011) -
Purification, chemical analysis and inhibitory effects on galectin-3 of enzymatic pH-modified citrus pectin
por: Zhang, Tao, et al.
Publicado: (2021) -
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice
por: Lu, Yonggang, et al.
Publicado: (2017)